Xanomeline tartrate, trospium chloride, risperidone, lurasidone clinical trials

The efficacy of xanomeline-trospium in treating cognitive impairment in patients with a psychotic disorder

This study is looking for people aged 18-55 with early psychosis to test a new medicine, xanomeline-trospium. It aims to see if this new medicine can better help with thinking, memory, and concentration problems compared to usual treatments.